Display Settings:

Format

Send to:

Choose Destination
    Cleve Clin J Med. 2011 Apr;78(4):243-57.

    Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others.

    Source

    Department of Pharmacology, Division of Clinical Trials, College of Medicine, The Ohio State University, Columbus, USA. joseph.kitzmiller@osumc.edu

    Abstract

    Genetics may account for much of the variability in our patients' responses to drug therapies. This article offers the clinician an up-to-date overview of pharmacogenomic testing, discussing implications and limitations of emerging validated tests relevant to the use of warfarin (Coumadin), clopidogrel (Plavix), statins, tamoxifen (Nolvadex), codeine, and psychotropic drugs. It also discusses the future role of pharmacogenomic testing in medicine.

    PMID:
    21460130
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk